Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Abstract Background Little is known about the nature of metastasis to small cervical lymph nodes (SCLNs) in the patients with nasopharyngeal carcinoma (NPC) examined by using 18-fluoro-2-deoxy-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). The present study aimed to eva...

Full description

Bibliographic Details
Main Authors: Hao Peng, Lei Chen, Ling-Long Tang, Wen-Fei Li, Yan-Ping Mao, Rui Guo, Yuan Zhang, Li-Zhi Liu, Li Tian, Xu Zhang, Xiao-Ping Lin, Ying Guo, Ying Sun, Jun Ma
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Chinese Journal of Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40880-017-0265-9
_version_ 1811304715875516416
author Hao Peng
Lei Chen
Ling-Long Tang
Wen-Fei Li
Yan-Ping Mao
Rui Guo
Yuan Zhang
Li-Zhi Liu
Li Tian
Xu Zhang
Xiao-Ping Lin
Ying Guo
Ying Sun
Jun Ma
author_facet Hao Peng
Lei Chen
Ling-Long Tang
Wen-Fei Li
Yan-Ping Mao
Rui Guo
Yuan Zhang
Li-Zhi Liu
Li Tian
Xu Zhang
Xiao-Ping Lin
Ying Guo
Ying Sun
Jun Ma
author_sort Hao Peng
collection DOAJ
description Abstract Background Little is known about the nature of metastasis to small cervical lymph nodes (SCLNs) in the patients with nasopharyngeal carcinoma (NPC) examined by using 18-fluoro-2-deoxy-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). The present study aimed to evaluate the diagnostic values of PET/CT in identifying metastasis in SCLNs in NPC patients. Methods Magnetic resonance images (MRI) and PET/CT scans for 470 patients with newly diagnosed, non-distant metastatic NPC were analyzed. Metastatic rates of SCLNs were defined by the positive number of SCLNs on PET/CT scans and total number of SCLNs on MRI scans. Receiver operating characteristic curve was applied to compare PET/CT-determined stage with MRI-determined stage. Results In total, 2082 SCLNs were identified, with 808 (38.8%) ≥ 5 and < 6 mm in diameter (group A), 526 (25.3%) ≥ 6 and < 7 mm in diameter (group B), 374 (18.0%) ≥ 7 and < 8 mm in diameter (group C), 237 (11.4%) ≥ 8 and < 9 mm in diameter (group D), and 137 (6.5%) ≥ 9 and < 10 mm in diameter (group E). The overall metastatic rates examined by using PET/CT for groups A, B, C, D, and E were 3.5%, 8.0%, 31.3%, 60.0%, and 83.9%, respectively (P < 0.001). In level IV/Vb, the metastatic rate for nodes ≥ 8 mm was 84.6%. PET/CT examination resulted in modification of N category and overall stage for 135 (28.7%) and 46 (9.8%) patients, respectively. The areas under curve of MRI-determined and PET/CT-determined overall stage were 0.659 and 0.704 for predicting overall survival, 0.661 and 0.711 for predicting distant metastasis-free survival, and 0.636 and 0.663 for predicting disease-free survival. Conclusions PET/CT was more effective than MRI in identifying metastatic SCLNs, and the radiologic diagnostic criteria for metastatic lymph nodes in level IV/Vb should be re-defined.
first_indexed 2024-04-13T08:12:20Z
format Article
id doaj.art-40b1b2abf3e6491ab7ce4bd43880cab6
institution Directory Open Access Journal
issn 1944-446X
language English
last_indexed 2024-04-13T08:12:20Z
publishDate 2017-12-01
publisher BMC
record_format Article
series Chinese Journal of Cancer
spelling doaj.art-40b1b2abf3e6491ab7ce4bd43880cab62022-12-22T02:54:55ZengBMCChinese Journal of Cancer1944-446X2017-12-0136111010.1186/s40880-017-0265-9Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapyHao Peng0Lei Chen1Ling-Long Tang2Wen-Fei Li3Yan-Ping Mao4Rui Guo5Yuan Zhang6Li-Zhi Liu7Li Tian8Xu Zhang9Xiao-Ping Lin10Ying Guo11Ying Sun12Jun Ma13Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterImaging Diagnosis and Interventional Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterImaging Diagnosis and Interventional Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Nuclear Medicine, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Nuclear Medicine, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Clinical Trials Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterAbstract Background Little is known about the nature of metastasis to small cervical lymph nodes (SCLNs) in the patients with nasopharyngeal carcinoma (NPC) examined by using 18-fluoro-2-deoxy-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). The present study aimed to evaluate the diagnostic values of PET/CT in identifying metastasis in SCLNs in NPC patients. Methods Magnetic resonance images (MRI) and PET/CT scans for 470 patients with newly diagnosed, non-distant metastatic NPC were analyzed. Metastatic rates of SCLNs were defined by the positive number of SCLNs on PET/CT scans and total number of SCLNs on MRI scans. Receiver operating characteristic curve was applied to compare PET/CT-determined stage with MRI-determined stage. Results In total, 2082 SCLNs were identified, with 808 (38.8%) ≥ 5 and < 6 mm in diameter (group A), 526 (25.3%) ≥ 6 and < 7 mm in diameter (group B), 374 (18.0%) ≥ 7 and < 8 mm in diameter (group C), 237 (11.4%) ≥ 8 and < 9 mm in diameter (group D), and 137 (6.5%) ≥ 9 and < 10 mm in diameter (group E). The overall metastatic rates examined by using PET/CT for groups A, B, C, D, and E were 3.5%, 8.0%, 31.3%, 60.0%, and 83.9%, respectively (P < 0.001). In level IV/Vb, the metastatic rate for nodes ≥ 8 mm was 84.6%. PET/CT examination resulted in modification of N category and overall stage for 135 (28.7%) and 46 (9.8%) patients, respectively. The areas under curve of MRI-determined and PET/CT-determined overall stage were 0.659 and 0.704 for predicting overall survival, 0.661 and 0.711 for predicting distant metastasis-free survival, and 0.636 and 0.663 for predicting disease-free survival. Conclusions PET/CT was more effective than MRI in identifying metastatic SCLNs, and the radiologic diagnostic criteria for metastatic lymph nodes in level IV/Vb should be re-defined.http://link.springer.com/article/10.1186/s40880-017-0265-9Nasopharyngeal carcinoma18-fluoro-2-deoxy-glucose positron emission tomography with computed tomography (18F-PET/CT)Magnetic resonance imageIntensity-modulated radiotherapySmall cervical lymph nodes
spellingShingle Hao Peng
Lei Chen
Ling-Long Tang
Wen-Fei Li
Yan-Ping Mao
Rui Guo
Yuan Zhang
Li-Zhi Liu
Li Tian
Xu Zhang
Xiao-Ping Lin
Ying Guo
Ying Sun
Jun Ma
Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
Chinese Journal of Cancer
Nasopharyngeal carcinoma
18-fluoro-2-deoxy-glucose positron emission tomography with computed tomography (18F-PET/CT)
Magnetic resonance image
Intensity-modulated radiotherapy
Small cervical lymph nodes
title Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
title_full Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
title_fullStr Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
title_full_unstemmed Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
title_short Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
title_sort significant value of 18f fdg pet ct in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity modulated radiotherapy
topic Nasopharyngeal carcinoma
18-fluoro-2-deoxy-glucose positron emission tomography with computed tomography (18F-PET/CT)
Magnetic resonance image
Intensity-modulated radiotherapy
Small cervical lymph nodes
url http://link.springer.com/article/10.1186/s40880-017-0265-9
work_keys_str_mv AT haopeng significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT leichen significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT linglongtang significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT wenfeili significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT yanpingmao significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT ruiguo significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT yuanzhang significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT lizhiliu significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT litian significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT xuzhang significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT xiaopinglin significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT yingguo significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT yingsun significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT junma significantvalueof18ffdgpetctindiagnosingsmallcervicallymphnodemetastasesinpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy